Fig. 4
From: The changing landscape of drug clinical trials on cardiometabolic diseases in China, 2009–2021
Distribution of indications in cardiometabolic drug clinical trials
(A) Number of clinical trials according to the indication in cardiometabolic diseases. (B) Trials are divided into monomer drug, chemical polypill, and TCM compound. (C) The number of drug trials for different indications. Blue represents one indication. Green represents two indications. Yellow represents three indications, and red represents four indications. (D) In the chemical polypill, the number of drug trials for different indications. The blue represents one indication which suggested that the polypill for one indication. The green represents two indications for polypill. The yellow represents three indications and the red represents four indications. (E) In TCM compounds, the number of drug trials for different indications. The blue represents one indication and the green represents two indications. Numbers above each column of the chart represent the actual number of trials. Abbreviations: TCM, Traditional Chinese Medicine